HSPG2 and prostate carcinoma: The results of interference with Perlecan function demonstrate that this proteoglycan is required for the growth of prostate cancer cells, extending its previously described roles in melanoma, colon, and lung cancer [20-22] and emphasizing Perlecan's role in multiple tumor types.